Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 13Nivolumab 6Cyclophosphamide 6Carboplatin 6Specimen Handling 5Pemetrexed 5Paclitaxel 5Docetaxel 5Cisplatin 5Cetuximab 5Bevacizumab 5fludarabine phosphate 4fludarabine 4atezolizumab 4tislelizumab 3durvalumab 3Standard of Care 3Practice Guidelines as Topic 3Methods 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Gemcitabine 3Educational Status 3Early Intervention, Educational 3130-nm albumin-bound paclitaxel 3venetoclax 2tremelimumab 2temsirolimus 2niraparib 2ixazomib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anterior Temporal Lobectomy × 30 days × Clear all
NCT03237377 2026-05-27

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
9 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡